デフォルト表紙
市場調査レポート
商品コード
1670964

構造心臓の世界市場レポート 2025

Structural Heart Global Market Report 2025


出版日
ページ情報
英文 200 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.33円
構造心臓の世界市場レポート 2025
出版日: 2025年02月28日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

構造心臓市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.8%で224億3,000万米ドルに成長します。予測期間の成長は、心臓弁装置の需要、高齢化、心血管疾患の負担増、市場セグメンテーション、地域市場の成長に起因しています。予測期間の主な動向には、製品の発売、技術の進歩、景気回復、規制強化、心血管疾患の増加、革新的な医療機器などがあります。

予測される心血管疾患の増加は、今後の構造心臓市場の成長を牽引すると期待されます。心血管疾患には、冠動脈疾患、心不全、脳卒中などの心臓や血管に影響を及ぼす疾患が含まれます。心血管障害の有病率の増加は、主に高齢化、ライフスタイルや食生活の変化、肥満や糖尿病の割合の増加などの要因によるものです。構造心臓機器とサービスは、心臓の弁、心室、周辺組織に影響を及ぼす異常や障害の診断と治療において重要な役割を果たしており、開心術の代わりに低侵襲処置を採用することで、より低リスクの合併症で効率的な治療を実現しています。例えば、米国心臓病学会(American College of Cardiology)が2022年8月に発表した報告書によると、米国では2025年から2060年にかけて4つの心血管危険因子すべてが増加し、糖尿病は39.3%増の5,500万人に達すると予測されています。

肥満の動向は構造心臓市場の拡大に貢献すると予測されます。肥満症は、体脂肪の過剰な蓄積によって体格指数(BMI)が30以上になることを特徴とし、心血管課題の高まりに関連する病状です。世界の肥満の蔓延は、肥満に関連する心血管リスクの増大に対処するための高度な構造心臓介入への需要を牽引しています。2022年5月の世界肥満連盟の報告書に示されたように、2030年までに、女性の5人に1人、男性の7人に1人を含む10億人が肥満とともに生活し、この数は2035年までに40億人、世界人口の51%に増加すると予測されています。このように、肥満の割合の増加は、構造心臓市場の成長の舵取り役となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場:金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界構造心臓PESTEL分析(政治、社会、技術、環境、法的要因、促進要因、抑制要因)
  • 最終用途産業の分析
  • 世界の構造心臓市場:成長率分析
  • 世界の構造心臓市場の実績:規模と成長, 2019-2024
  • 世界の構造心臓市場の予測:規模と成長, 2024-2029, 2034F
  • 世界構造心臓総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界の構造心臓市場:製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 閉塞物
  • 環状形成リング
  • 心臓弁バルーン
  • その他の製品
  • 世界の構造心臓市場手順別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 心臓弁狭窄症
  • 心臓弁逆流症
  • 左心耳閉鎖
  • 世界の構造心臓市場:エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院
  • 外来手術センター
  • 心臓センター
  • 世界の構造心臓市場、オクルーダーのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 心房中隔欠損(ASD)閉塞器具
  • 卵円孔開存症(PFO)閉塞器具
  • 心室中隔欠損(VSD)閉塞器具
  • 世界の構造心臓市場、タイプ別環状形成リングのサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 硬質環状形成リング
  • フレキシブルな環状形成リング
  • 調節可能な環状形成リング
  • 世界の構造心臓市場、心臓弁バルーンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • バルーン拡張型心臓弁システム
  • 弁形成術用バルーン
  • 世界の構造心臓市場、その他の製品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 経カテーテル心臓弁
  • 構造心臓イメージングデバイス
  • 構造心臓手順の配信システム

第7章 地域別・国別分析

  • 世界の構造心臓市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の構造心臓市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 構造心臓市場:競合情勢
  • 構造心臓市場:企業プロファイル
    • Abbott Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Trane Technologies Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Lepu Medical Technology Co. Ltd.
  • LivaNova PLC
  • Biomerics LLC
  • Venus Medtech(Hangzhou)Inc.
  • Cryolife Inc.
  • Endologix Inc.
  • Shockwave Medica Inc.
  • Braile Biomedica
  • JenaValve Technology Inc.
  • Corvia Medical Inc
  • HLT Medical
  • On-X Life Technologies Inc.
  • Symetis SA
  • Magenta Therapeutics
  • PASCAL Medical

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 構造心臓市場2029:新たな機会を提供する国
  • 構造心臓市場2029:新たな機会を提供するセグメント
  • 構造心臓市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r25335

Structural heart is a subspecialty within cardiology that concentrates on diagnosing and treating structural abnormalities or diseases of the heart, particularly those impacting the valves, chambers, and surrounding structures. This field typically involves minimally invasive procedures conducted in a catheterization laboratory as opposed to traditional open-heart surgery.

The primary categories of structural heart products encompass occluders, annuloplasty rings, heart valve balloons, and other related devices. Occluder systems are specifically designed to provide a conduit for delivering devices into the heart's chambers, coronary arteries, and peripheral vasculature. These devices are utilized in patients with specific types of atrial septal defects featuring right atrial or ventricle enlargement, preventing paradoxical embolism. The diverse procedures employing structural heart products include heart valve stenosis, heart valve regurgitation, and left atrial appendage closure. These procedures cater to various end-users such as hospitals, ambulatory surgical centers, and cardiac centers.

The structural heart market research report is one of a series of new reports from The Business Research Company that provides structural heart market statistics, including structural heart industry global market size, regional shares, competitors with a structural heart market share, detailed structural heart market segments, market trends and opportunities, and any further data you may need to thrive in the structural heart industry. This structural heart market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The structural heart market size has grown strongly in recent years. It will grow from $14.9 billion in 2024 to $15.99 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increased awareness and screening, supply chain resilience, increasing healthcare expenditure, market concentration, and increasing awareness of cardiovascular diseases

The structural heart market size is expected to see strong growth in the next few years. It will grow to $22.43 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to the demand for heart valve devices, aging population, growing burden of cardiovascular diseases, market segmentation, regional market growth. Major trends in the forecast period include product launches, technological advancements, economic recovery, regulatory impositions, rising incidences of cardiovascular diseases, and innovative medical devices.

The anticipated rise in cardiovascular disorders is expected to drive the growth of the structural heart market in the future. Cardiovascular disorders encompass diseases affecting the heart and blood vessels, including conditions such as coronary artery disease, heart failure, and stroke. The increasing prevalence of cardiovascular disorders is primarily attributed to factors such as the aging population, shifts in lifestyle and diet, and escalating rates of obesity and diabetes. Structural heart devices and services play a crucial role in diagnosing and treating anomalies or disorders affecting the valves, chambers, and surrounding tissues of the heart, employing minimally invasive procedures instead of open-heart surgery to ensure efficient treatment with lower-risk complications. For example, a report published by the American College of Cardiology in August 2022 highlighted the projected increase in all four cardiovascular risk factors in the United States between 2025 and 2060, with diabetes expected to see a 39.3% rise to 55 million individuals, underscoring the significant role of cardiovascular disorders in propelling the structural heart market's growth.

The upward trend in obesity rates is anticipated to contribute to the expansion of the structural heart market. Obesity, characterized by excessive body fat accumulation resulting in a body mass index (BMI) of 30 or higher, is a medical condition associated with heightened cardiovascular challenges. The persistent global obesity epidemic drives the demand for advanced structural heart interventions to address the increased cardiovascular risks linked to obesity. As indicated by a report from the World Obesity Federation in May 2022, it is projected that by 2030, one billion people globally, including 1 in 5 women and 1 in 7 men, will be living with obesity, and this number is expected to increase to 4 billion people or 51% of the global population by 2035. Thus, the escalating rates of obesity are instrumental in steering the growth of the structural heart market.

Technological advancements have emerged as a prominent trend gaining traction in the structural heart market. Leading market players are channeling their efforts into creating innovative products to strengthen their market position. For instance, in February 2023, Eko Health, a US-based digital health company, introduced the SENSORA cardiac disease detection platform, utilizing artificial intelligence for non-invasive heart disease detection in primary care. SENSORA features digital stethoscopes to capture and analyze heart sounds and electrical signals, aiding in key decision-making by identifying structural murmurs, a sign of valvular heart disease. This technology enhances operational efficiency by reducing delays in care delivery, length of stay, and readmission rates, contributing to both patient and physician satisfaction.

Key players in the structural heart market are innovating advanced products, including transcatheter edge-to-edge repair (TEER) systems, to improve minimally invasive treatment options for heart valve diseases. TEER systems are minimally invasive medical devices designed to address heart valve conditions, particularly mitral valve regurgitation. For example, in April 2024, Abbott Laboratories, a US-based medical device firm, gained approval from the Food and Drug Administration (FDA), a US federal agency responsible for safeguarding public health, for its device called TriClip. TriClip is an innovative TEER system that is delivered through a vein in the leg, allowing for valve repair without the need for open-heart surgery, making it suitable for patients who might be at greater risk due to age or pre-existing health conditions. The device operates by using clips to grasp and bring together the leaflets of the tricuspid valve, thereby decreasing regurgitation and enhancing blood flow.

In February 2022, Genesis MedTech, a Singapore-based medical technology company, acquired JC Medical (JCM), a US-based company operating in the structural heart market, for an undisclosed amount. This acquisition enables Genesis MedTech to enhance its product portfolio with J-Valve, a minimally invasive transcatheter aortic valve replacement (TAVR) device, reinforcing its position in the market by offering comprehensive solutions for structural heart disease.

Major companies operating in the structural heart market include Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Trane Technologies, Lepu Medical Technology Co. Ltd., LivaNova PLC, Biomerics LLC, Venus Medtech (Hangzhou) Inc., Cryolife Inc., Endologix Inc., Shockwave Medica Inc., Braile Biomedica, JenaValve Technology Inc., Corvia Medical Inc, HLT Medical, On-X Life Technologies Inc., Symetis SA, Magenta Therapeutics, PASCAL Medical, Micro Interventional Devices Inc., CardioKinetix Inc, Tendyne Holdings Inc., Q'Apel Medical Inc., Neovasc Inc., NVT AG, Z-Medical GmbH + Co. KG

North America was the largest region in the structural heart market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the structural heart market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The structural heart market consists of revenues earned by entities by providing services such as patient evaluation, diagnosis, treatment planning, surgical or interventional procedures, and follow-up care. The market value includes the value of related goods sold by the service provider or included within the service offering. The structural heart market also includes sales of transcatheter heart valves, closure devices, and implantable devices that are used during procedures. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Structural Heart Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on structural heart market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for structural heart ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The structural heart market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Occluders; Annuloplasty Rings; Heart Valve Balloons; Other Products
  • 2) By Procedure: Heart Valve Stenosis; Heart Valve Regurgitation; Left Atrial Appendage Closure
  • 3) By End Users: Hospitals; Ambulatory Surgical Centers; Cardiac Centers
  • Subsegments:
  • 1) By Occluders: Atrial Septal Defect (ASD) Occluders; Patent Foramen Ovale (PFO) Occluders; Ventricular Septal Defect (VSD) Occluders
  • 2) By Annuloplasty Rings: Rigid Annuloplasty Rings; Flexible Annuloplasty Rings; Adjustable Annuloplasty Rings
  • 3) By Heart Valve Balloons: Balloon Expandable Heart Valve Systems; Valvuloplasty Balloons
  • 4) By Other Products: Transcatheter Heart Valves; Structural Heart Imaging Devices; Delivery Systems For Structural Heart Procedures
  • Companies Mentioned: Abbott Laboratories; Medtronic plc; Boston Scientific Corporation; Edwards Lifesciences Corporation; Trane Technologies
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Structural Heart Market Characteristics

3. Structural Heart Market Trends And Strategies

4. Structural Heart Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Structural Heart Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Structural Heart PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Structural Heart Market Growth Rate Analysis
  • 5.4. Global Structural Heart Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Structural Heart Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Structural Heart Total Addressable Market (TAM)

6. Structural Heart Market Segmentation

  • 6.1. Global Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Occluders
  • Annuloplasty Rings
  • Heart Valve Balloons
  • Other Products
  • 6.2. Global Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Heart Valve Stenosis
  • Heart Valve Regurgitation
  • Left Atrial Appendage Closure
  • 6.3. Global Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Centers
  • 6.4. Global Structural Heart Market, Sub-Segmentation Of Occluders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Atrial Septal Defect (ASD) Occluders
  • Patent Foramen Ovale (PFO) Occluders
  • Ventricular Septal Defect (VSD) Occluders
  • 6.5. Global Structural Heart Market, Sub-Segmentation Of Annuloplasty Rings, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rigid Annuloplasty Rings
  • Flexible Annuloplasty Rings
  • Adjustable Annuloplasty Rings
  • 6.6. Global Structural Heart Market, Sub-Segmentation Of Heart Valve Balloons, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Balloon Expandable Heart Valve Systems
  • Valvuloplasty Balloons
  • 6.7. Global Structural Heart Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transcatheter Heart Valves
  • Structural Heart Imaging Devices
  • Delivery Systems For Structural Heart Procedures

7. Structural Heart Market Regional And Country Analysis

  • 7.1. Global Structural Heart Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Structural Heart Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Structural Heart Market

  • 8.1. Asia-Pacific Structural Heart Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Structural Heart Market

  • 9.1. China Structural Heart Market Overview
  • 9.2. China Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Structural Heart Market

  • 10.1. India Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Structural Heart Market

  • 11.1. Japan Structural Heart Market Overview
  • 11.2. Japan Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Structural Heart Market

  • 12.1. Australia Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Structural Heart Market

  • 13.1. Indonesia Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Structural Heart Market

  • 14.1. South Korea Structural Heart Market Overview
  • 14.2. South Korea Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Structural Heart Market

  • 15.1. Western Europe Structural Heart Market Overview
  • 15.2. Western Europe Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Structural Heart Market

  • 16.1. UK Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Structural Heart Market

  • 17.1. Germany Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Structural Heart Market

  • 18.1. France Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Structural Heart Market

  • 19.1. Italy Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Structural Heart Market

  • 20.1. Spain Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Structural Heart Market

  • 21.1. Eastern Europe Structural Heart Market Overview
  • 21.2. Eastern Europe Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Structural Heart Market

  • 22.1. Russia Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Structural Heart Market

  • 23.1. North America Structural Heart Market Overview
  • 23.2. North America Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Structural Heart Market

  • 24.1. USA Structural Heart Market Overview
  • 24.2. USA Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Structural Heart Market

  • 25.1. Canada Structural Heart Market Overview
  • 25.2. Canada Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Structural Heart Market

  • 26.1. South America Structural Heart Market Overview
  • 26.2. South America Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Structural Heart Market

  • 27.1. Brazil Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Structural Heart Market

  • 28.1. Middle East Structural Heart Market Overview
  • 28.2. Middle East Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Structural Heart Market

  • 29.1. Africa Structural Heart Market Overview
  • 29.2. Africa Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Structural Heart Market Competitive Landscape And Company Profiles

  • 30.1. Structural Heart Market Competitive Landscape
  • 30.2. Structural Heart Market Company Profiles
    • 30.2.1. Abbott Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Trane Technologies Overview, Products and Services, Strategy and Financial Analysis

31. Structural Heart Market Other Major And Innovative Companies

  • 31.1. Lepu Medical Technology Co. Ltd.
  • 31.2. LivaNova PLC
  • 31.3. Biomerics LLC
  • 31.4. Venus Medtech (Hangzhou) Inc.
  • 31.5. Cryolife Inc.
  • 31.6. Endologix Inc.
  • 31.7. Shockwave Medica Inc.
  • 31.8. Braile Biomedica
  • 31.9. JenaValve Technology Inc.
  • 31.10. Corvia Medical Inc
  • 31.11. HLT Medical
  • 31.12. On-X Life Technologies Inc.
  • 31.13. Symetis SA
  • 31.14. Magenta Therapeutics
  • 31.15. PASCAL Medical

32. Global Structural Heart Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Structural Heart Market

34. Recent Developments In The Structural Heart Market

35. Structural Heart Market High Potential Countries, Segments and Strategies

  • 35.1 Structural Heart Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Structural Heart Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Structural Heart Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer